Titan Medical TMDI

$ 0.14 -26.32%

Annual report 2020
added 08-19-2023

Titan Medical Financial Statements 2011-2024 | TMDI

Annual Financial Statements Titan Medical

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	115 M	15.3 M	20.3 M	71.1 M	57.2 M	95.9 M	136 M	110 M	79.6 M	82.5 M
Shares	-	67 M	30.7 M	16.6 M	7.9 M	4.88 M	3.48 M	3.14 M	2.34 M	2.14 M	1.81 M
Historical Prices	0.63	1.71	0.5	1.22	9	7.2	22.5	36	26.1	36.6	39.6
Net Income	-14.9 M	-24.2 M	-41.9 M	-22.6 M	-33.6 M	-23.3 M	-41.4 M	-13.5 M	-9.07 M	-7.76 M	-15.8 M
Revenue	20.1 M	20 M	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-31 M	4.15 M	-59.3 M	-	-	-	-	-	-	-	-
Interest Expense	-	1.09 M	423 K	-	-	-	-	-	-	-	-
EBITDA	-31 M	4.15 M	-59.3 M	-	-	-27.8 M	-42.6 M	-14.8 M	-8.83 M	-7.72 M	-15.8 M
Operating Expenses	-	-	59.3 M	39.7 M	18.9 M	27.5 M	41.8 M	14.2 M	8.83 M	7.88 M	-
General and Administrative Expenses	12.4 M	7.49 M	7.81 M	6.8 M	5.97 M	4.93 M	3.53 M	3.5 M	3.48 M	3.08 M	3.07 M

All numbers in USD currency

Quarterly Income Statement Titan Medical

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	-	-	-	-	-	-	80.5 M	60.8 M	-	-	32 M	31.2 M	-	-	18.3 M	13.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-9.22 M	-	-8.56 M	-940 K	-14.8 M	-	-1.64 M	-1.14 M	-768 K	-	-14.5 M	-14.5 M	-	-	7.53 M	5.89 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	10 M	50 K	-	-	10 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-12.1 M	-	-14.1 M	-2.02 M	-11.8 M	-	-4.52 M	7.46 M	-1.73 M	-	-18.5 M	-21.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	592 K	253 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-12.1 M	-	-14.1 M	-2.02 M	-11.8 M	-	-4.52 M	7.46 M	-1.73 M	-	-18.5 M	-21.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	2.53 M	-	3.38 M	4.84 M	4.07 M	-	2.22 M	2.39 M	1.67 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency